BD (Becton, Dickinson and Company), a global leader in medical technology, has announced a landmark strategic partnership with Wellstar Health…
Read More
FDA Commissioner Marty Makary Resigns Amid Pressure from Administration, Citing Policy Conflicts and Agency Instability
Marty Makary resigned on Tuesday as commissioner of the Food and Drug Administration, effective immediately, amidst a period of intense…
Read More
Small study suggests probiotic yogurt strain may boost immunotherapy response in lung cancer
Immunotherapy has fundamentally reshaped the landscape of lung cancer treatment, offering a beacon of hope and significantly improving patient prognoses.…
Read More
Novo Nordisk hands a Parkinson’s cell therapy to Cellular Intelligence, a startup trying to design cell behavior
Cellular Intelligence, a burgeoning biotechnology firm formerly known as Somite AI, has announced a significant strategic acquisition, securing global rights…
Read More
Rubedo turns a senescence-targeting drug on precancerous skin, and sees an efficacy signal without the intense redness
For millions globally afflicted by actinic keratoses (AKs), the rough, scaly patches of sun-damaged skin that serve as precursors to…
Read More
Insilico CEO sees potentially $2.75 billion collaboration as ‘fusing Lilly’s clinical excellence’ with Insilico’s ‘end-to-end AI engine’
A transformative partnership has been forged between Insilico Medicine, a pioneer in artificial intelligence-driven drug discovery, and Eli Lilly, a…
Read More
Amazon Bio Discovery cut MSK antibody design from a year to weeks, AWS says.
Amazon Web Services (AWS) has announced the launch of Amazon Bio Discovery, a groundbreaking application designed to revolutionize the speed…
Read More
Salesforce lands 140 life sciences clients, pitches ‘headless’ AI to pharma
In a strategic maneuver that underscores the intensifying competition in the life sciences technology sector, Salesforce has announced that over…
Read More
How Immuto Scientific pairs AI and mass spec for a step change in protein structure throughput
Immuto Scientific, a trailblazing company co-founded in 2018 by CEO Faraz A. Choudhury, Ph.D., and CTO Daniel Benjamin, Ph.D., both…
Read More
Lilly’s plans to buy CAR-T firm Kelonia in deal worth up to $7 billion. Can its deal spree avoid Pfizer’s fate?
Eli Lilly and Company is embarking on a significant acquisition spree, exemplified by its recent agreement to acquire Kelonia Therapeutics…
Read MoreYOU MAY HAVE MISSED
